- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- N-(4-(1-cyanocyclopentyl)phenyl)-2-(4-pyridinylmethyl)amino-
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
N-(4-(1-cyanocyclopentyl)phenyl)-2-(4-pyridinylmethyl)amino-3-pyridinecarboxamide methanesulfonate
| EU orphan designation number: | EU/3/17/1840
|
| Active ingredient: | N-(4-(1-cyanocyclopentyl)phenyl)-2-(4-pyridinylmethyl)amino-3-pyridinecarboxamide methanesulfonate |
| Indication: | Treatment of gastric cancer |
| Sponsor: | Sirius Regulatory Consulting Limited
29 Hamblin Meadow, Eddington, Hungerford, Berkshire, RG17 0HJ, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 01/03/2017 | Orphan designation | EMA/OD/228/16 | (2017)1506 of 27/02/2017 |
CONTACT
EU links
Directorate General Health & Consumers